Role of nuclear factor kappa B in neuropathological mechanisms

Progress in Brain Research

Volumn 132, Issue , 2001, Pages 391-404

  Cechetto, David F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMYLOID BETA PROTEIN; BENZOIC ACID DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOOXYGENASE 2; CYTOKINE; DIZOCILPINE; EXCITATORY AMINO ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; KAINIC ACID; LACTATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN S 100; QUINOLINIC ACID; TRANSCRIPTION FACTOR; TRIFLUSAL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANIMAL TISSUE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; DEMENTIA; EPILEPSY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPATHOLOGY; KNOCKOUT MOUSE; MOUSE; NERVE CELL CULTURE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0035783530     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(01)32090-3     Document Type: Article

References (86)

1. Acarin, L., Gonzalez, B. and Castellano, B. (2000) STAT3 and NFkappaB activation precedes glial reactivity in the excitotoxically injured young cortex but not in the corresponding distal thalamic nuclei. J. Neuropathol. Exp. Neurol., 59: 151-163.
2. Acarin, L., Gonzalez, B. and Castellano, B. (1998) Stat3 and Nfkappab glial expression after excitotoxic damage to the postnatal brain. NeuroReport, 9: 2869-2873.
3. Akama, K.T., Albanese, C., Pestell, R.G. and Van Eldik, L.J. (1998) Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an Nfkappab-dependent mechanism. Proc. Natl. Acad. Sci. USA, 95: 5795-5800.
4. Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A. and Karin, M. (1995) Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science, 270: 86-290.
5. Baeuerle, P.A. and Henkel, T. (1994) Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol., 12: 141-179.
6. Bales, K.R., Du, Y., Dodel, R.C., Yan, G.M., Hamilton-Byrd, E. and Paul, S.M. (1998) The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. Mol. Brain Res., 57: 63-72.
7. Barger, S.W. and Mattson, M.P. (1996a) Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Mol. Brain Res., 40: 116-126.
8. Barger, S.W. and Mattson, M.P. (1996b) Participation of gene expression in the protection against amyloid beta-peptide toxicity by the beta-amyloid precursor protein. Ann. New York Acad. Sci., 777: 303-309.
9. Barger, S.W., Horster, D., Furukawa, K., Goodman, Y., Krieglstein, J. and Mattson, M.P. (1995) Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: Evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc. Natl. Acad. Sci. USA, 92: 9328-9332.
10. Bayón, Y., Alonso, A. and Sanchez, C.M. (1999) 4-Trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation. Br. J. Pharmacol., 126: 1359-1366.
11. Behl, C. and Sagara, Y. (1997) Mechanism of amyloid beta protein induced neuronal cell death: Current concepts and future perspectives. J. Neural Transm. Suppl., 49: 125-134.
12. Boissiere, F., Hunot, S., Faucheux, B., Duyckaerts, C., Hauw, J.J., Agid, Y. and Hirsch, E.C. (1997) Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease. NeuroReport, 8: 2849-2852.
13. Botchkina, G.I., Geimonen, E., Bilof, M.L., Villarreal, O. and Tracey, K.J. (1999) Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity. Mol. Med., 5: 372-381.
14. Buchan, A.M., Li, H. and Blackburn, B. (2000) Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-kappaB activation. NeuroReport, 11: 427-430.
15. Carroll, J.E., Howard, E.F., Hess, D.C., Wakade, C.G., Chen, Q. and Cheng, C. (1998) Nuclear factor-kappa B activation during cerebral reperfusion: Effect of attenuation with N-acetylcysteine treatment. Mol. Brain Res., 56: 186-191.
16. Choi, D.W. (1995) Calcium: Still center-stage in hypoxicischemic neuronal death. Trends. Neurosci., 18: 58-60.
17. Chopp, M., Li, Y., Zhang, Z.G. and Freytag, S.O. (1992) p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem. Biophys. Res. Commun., 182: 1201-1207.
18. Clemens, J.A., Stephenson, D.T., Dixon, E.P., Smalstig, E.B., Mincy, R.E., Rash, K.S. and Little, S.P. (1997a) Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Mol. Brain Res., 48: 187-196.
19. Clemens, J.A., Stephenson, D.T., Smalstig, E.B., Dixon, E.P. and Little, S.P. (1997b) Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke, 28: 1073-1080.
20. Clemens, J.A., Stephenson, D.T., Yin, T., Smalstig, E.B., Panetta, J.A. and Little, S.P. (1998) Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats. Stroke, 29: 677-682.
21. Cruise, L., Ho, L.K., Veitch, K., Fuller, G. and Morris, B.J. (2000) Kainate receptors activate NF-kappaB via MAP kinase in striatal neurones. NeuroReport, 11: 395-398.
22. Dixon, E.P., Stephenson, D.T., Clemens, J.A. and Little, S.P. (1997) Bcl-Xshort is elevated following severe global ischemia in rat brains. Brain Res., 776: 222-229.
23. Dodel, R.C., Du, Y., Bales, K.R., Gao, F. and Paul, S.M. (1999) Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1-40) and lipopolysaccharides. J. Neurochem., 73: 1453-1460.
24. Farooqui, A.A. and Horrocks, L.A. (1994) Involvement of glutamate receptors, lipases, and phospholipases in long-term potentiation and neurodegeneration. J. Neurosci. Res., 38: 611.
25. Fernandez de Arriba, A., Cavalcanti, F., Miralles, A., Bayon, Y., Alonso, A., Merlos, M., Garcia-Rafanell, J. and Forn, J. (1999) Inhibition of cyclooxygenase-2 expression by 4trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid. Mol. Pharmacol., 55: 753-760.
26. Ferrer, I., Marti, E., Lopez, E. and Tortosa, A. (1998) NF-kB immunoreactivity is observed in association with beta A4 diffuse plaques in patients with Alzheimer's disease. Neuropathol. Appl. Neurobiol., 24: 271-277.
27. Fiebich, B.L., Hofer, T.J., Lieb, K., Huell, M., Butcher, R.D., Schumann, G., Schulze-Osthoff, K. and Bauer, J. (1999) The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha. Neuropharmacology, 38: 1325-1333.
28. Furukawa, K. and Mattson, M.P. (1998) The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J. Neurochem., 70: 1876-1886.
29. Gabriel, C., Justicia, C., Camins, A. and Planas, A.M. (1999) Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia. Mol. Brain Res., 65: 61-69.
30. Garcia, J.H., Liu, K.F. and Relton, J.K. (1995) Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol., 147: 1477-1486.
31. Grilli, M., Pizzi, M., Memo, M. and Spano, P. (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science, 274: 1383-1385.
32. Hamidi-Asl-Duvillé, R.S.S.S.a.D.F.C. (1999) Triflusal prevents neuronal cell death in cocultures of neurons and astrocytes induced by oxygen and glucose deprivation. Soc. Neurosci. Abstr., 25: 582.
33. Juurlink, B.H. and Sweeney, M.I. (1997) Mechanisms that result in damage during and following cerebral ischemia. Neurosci. Biobehav. Rev., 21: 121-128.
34. Kaltschmidt, B., Baeuerle, P.A. and Kaltschmidt, C. (1993) Potential involvement of the transcription factor NF-kappa B in neurological disorders. Mol. Aspects. Med., 14: 171-190.
35. Kaltschmidt, C., Kaltschmidt, B. and Baeuerle, P.A. (1995) Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc. Natl. Acad. Sci. USA, 92: 9618-9622.
36. Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H. and Baeuerle, P.A. (1994) Constitutive NF-kappa B activity in neurons. Mol. Cell Biol., 14: 3981-3992.
37. Kaltschmidt, B. and Kaltschmidt, C. (2000) Constitutive NFkappa B activity is modulated via neuron-astroglia interaction. Exp. Brain Res., 130: 100-104.
38. Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P.A. and Kaltschmidt, C. (1997) Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA, 94: 2642-2647.
39. Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B. and Kaltschmidt, C. (1999) Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc. Natl. Acad. Sci. USA, 96: 9409-9414.
40. Kastan, M.B., Canman, C.E. and Leonard, C.J. (1995) P53, cell cycle control and apoptosis: Implications for cancer. Cancer Metast. Rev., 14: 3-15.
41. Kitamura, Y., Shimohama, S., Ota, T., Matsuoka, Y., Nomura, Y. and Taniguchi, T. (1997) Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains. Neurosci. Lett., 237: 17-20.
42. Kopp, E. and Ghosh, S. (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin [see comments]. Science, 265: 956-959.
43. Li, Y., Barger, S.W., Liu, L., Mrak, R.E. and Griffin, W.S. (2000) S100beta induction of the proinflammatory cytokine interleukin-6 in neurons. J. Neurochem., 74: 143-150.
44. Li, Y., Chopp, M., Zhang, Z.G., Zaloga, C., Niewenhuis, L. and Gautam, S. (1994) p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke, 25: 849-855.
45. Lin, Y.Z., Yao, S.Y., Veach, R.A., Torgerson, T.R. and Hawiger, J. (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem., 270: 14255-14258.
46. Liu, T., Clark, R.K., McDonnell, P.C., Young, P.R., White, R.F., Barone, F.C. and Feuerstein, G.Z. (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke, 25: 14811-488.
47. Mao, X. and Barger, S.W. (1998) Neuroprotection by dehydroepiandrosterone-sulfate: Role of an NFkappaB-like factor. NeuroReport, 9: 759-763.
48. Mao, X., Moerman, A.M., Lucas, M.M. and Barger, S.W. (1999) Inhibition of the activity of a neuronal kappaB-binding factor by glutamate. J. Neurochem., 73: 1851-1858.
49. Matsuoka, Y., Kitamura, Y., Okazaki, M., Terai, K. and Taniguchi, T. (1999) Kainic acid-induced activation of nuclear factor-kappaB in rat hippocampus. Exp. Brain Res., 124: 215-222.
50. Mattson, M.P., Goodman, Y., Luo, H., Fu, W. and Furukawa, K. (1997) Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res., 49: 681-697.
51. Mody, I. and MacDonald, J.F. (1995) NMDA receptor-dependent excitotoxicity: The role of intracellular Ca2+ release. Trends Pharmacol. Sci., 16: 356-359.
52. Nakai, M., Qin, Z.H., Wang, Y. and Chase, T.N., (1999) Free radical scavenger OPC-14117 attenuates quinolinic acid-induced NF-kappaB activation and apoptosis in rat striatum. Brain Res. Mol. Brain Res., 64: 59-68.
53. Nawashiro, H., Martin, D. and Hallenbeck, J.M., (1997a) Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res., 778: 265-271.
54. Nawashiro, H., Tasaki, K., Ruetzler, C.A. and Hallenbeck, J.M., (1997b) TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab., 17: 483-490.
55. Nawashiro, H., Martin, D. and Hallenbeck, J.M., (1997c) Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J. Cereb. Blood Flow Metab., 17: 229-232.
56. Newton, R., Kuitert, L.M., Bergmann, M., Adcock, I.M. and Barnes, P.J. (1997) Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem. Biophys. Res. Commun., 237: 28-32.
57. Nonaka, M., Chen, X.H., Pierce, J.E., Leoni, M.J., McIntosh, T.K., Wolf, J.A. and Smith, D.H. (1999) Prolonged activation of NF-kappaB following traumatic brain injury in rats. J. Neurotrauma, 16: 1023-1034.
58. Opipari, A.W.J., Hu, H.M., Yabkowitz, R. and Dixit, V.M. (1992) The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem., 267: 12424-12427.
59. Packham, G. and Cleveland, J.L. (1995) c-Myc and apoptosis. Biochim. Biophys. Acta, 1242: 11-28.
60. Perez-Otano, I., McMillian, M.K., Chen, J., Bing, G., Hong, J.S. and Pennypacker, K.R. (1996) Induction of NF-kB-like transcription factors in brain areas susceptible to kainate toxicity. Glia, 16: 306-315.
61. Qin, Z.H., Chen, R.W., Wang, Y., Nakai, M., Chuang, D.M. and Chase, T.N. (1999) Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J. Neurosci., 19: 4023-4033.
62. Qin, Z.H., Wang, Y., Nakai, M. and Chase, T.N. (1998) Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum. Mol. Pharmacol., 53: 33-42.
63. Relton, J.K. and Rothwell, N.J. (1992) Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull., 29: 243-246.
64. Rong, Y. and Baudry, M. (1996) Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J. Neurochem., 67: 662-668.
65. Rothwell, N.J. and Relton, J.K. (1993) Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage. Cerebrovasc. Brain Metab. Rev., 5: 178-198.
66. Salminen, A., Liu, P.K. and Hsu, C.Y. (1995) Alteration of transcription factor binding activities in the ischemic rat brain. Biochem. Biophys. Res. Commun., 212: 939-944.
67. Scheinman, R.I., Cogswell, P.C., Lofquist, A.K. and Baldwin, A.S. (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science, 270: 283-286.
68. Schneider, A., Martin-Villalba, A., Weih, F., Vogel, J., Wirth, T. and Schwaninger, M. (1999) NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med., 5: 554-559.
69. Selivanova, G. and Wiman, K.G. (1995) p53: A cell cycle regulator activated by DNA damage. Adv. Cancer Res., 66: 143-180.
70. Sen, R. and Baltimore, D. (1986) Inducibility of k immunoglobulin enhancer-binding protein NFκB by a posttranslational mechanism. Cell, 47: 921-928.
71. Siushansian, R. and Wilson, J.X. (1995) Ascorbate transport and intracellular concentration in cerebral astrocytes. J. Neurochem., 65: 41-49.
72. Stephenson, D., Yin, T., Smalstig, E.B., Hsu, M.A., Panetta, J., Little, S. and Clemens, J. (2000) Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. J. Cereb. Blood Flow Metab., 20: 592-603.
73. Tagliatela, G., Robinson, R. and Perez-Polo, J.R. (1997) Inhibition of nuclear factor kappa B (NFkappaB) activity induces nerve growth factor-resistant apoptosis in PC12 cells. J. Neurosci. Res., 47: 155-162.
74. Terai, K., Matsuo, A., McGeer, E.G. and McGeer, P.L. (1996) Enhancement of immunoreactivity for NF-kappa B in human cerebral infarctions. Brain Res., 739: 343-349.
75. Thanos, D. and Maniatis, T. (1995) NF-κB: A lesson in family values. Cell, 80: 529-532.
76. Toliver-Kinsky, T., Papaconstantinou, J. and Perez-Polo, J.R. (1997) Age-associated alterations in hippocampal and basal forebrain nuclear factor kappa B activity. J. Neurosci. Res., 48: 580-587.
77. Vane, J.R. and Botting, R.M. (1998) Mechanism of action of antiinflammatory drugs. Int. J. Tissue React., 20: 3-15.
78. Verma, I.M., Stevenson, J.K., Schwarz, E.M., Van Antwerp, D. and Miyamoto, S. (1995) Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation. Genes Dev., 9: 2723-2735.
79. Wallace, J.L., McCafferty, D.M., Carter, L., McKnight, W. and Argentieri, D. (1993) Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: Anti-inflammatory without gastropathy? [see comments]. Gastroenterology, 105: 1630-1636.
80. Wang, Y., Qin, Z.H., Nakai, M., Chen, R.W., Chuang, D.M. and Chase, T.N. (1999) Co-stimulation of cyclic-AMP-linked metabotropic glutamate receptors in rat striatum attenuates excitotoxin-induced nuclear factor-kappaB activation and apoptosis. Neuroscience, 94: 1153-1162.
81. Weber, C., Erl, W., Pietsch, A. and Weber, P.C. (1995) Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation, 91: 1914-1917.
82. Weih, M., Bergk, A., Isaev, N.K., Ruscher, K., Megow, D., Riepe, M., Meisel, A., Victorov, I.V., Dirnagl, U. and Dirnagi, U. (1999) Induction of ischemic tolerance in rat cortical neurons by 3-nitropropionic acid: Chemical preconditioning [published erratum appears in Neurosci. Lett. 2000 Jan 14; 278(3):194]. Neurosci. Lett., 272: 207-210.
83. Won, S.J., Ko, H.W., Kim, E.Y., Park, E.C., Huh, K., Jung, N.P., Choi, I., Oh, Y.K., Shin, H.C. and Gwag, B.J. (1999) Nuclear factor kappa B-mediated kainate neurotoxicity in the rat and hamster hippocampus. Neuroscience, 94: 83-91.
84. Wong, G.H., Elwell, J.H., Oberley, L.W. and Goeddel, D.V. (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell, 58: 923-931.
85. Xuan, Y.T., Tang, X.L., Banerjee, S., Takano, H., Li, R.C., Han, H., Qiu, Y., Li, J.J. and Bolli, R. (1999) Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ. Res., 84: 1095-1109.
86. Yu, Z., Zhou, D., Bruce-Keller, A.J., Kindy, M.S. and Mattson, M.P. (1999) Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J. Neurosci., 19: 8856-8865.